Adar Poonawalla

According to media sources, the British multinational alcoholic beverage business is seeking a valuation of about $2 billion for RCB.

Adar Poonawalla talks about his decisions in Dharma Productions: Karan Johar has the creative freedom...

Adar Poonawalla, who recently acquired a 50% stake in Dharma Productions, affirmed that Karan Johar will retain full creative control. He emphasised their agreement allows Johar complete artistic freedom while he supports from the sidelines.

TPG seals deal to acquire 35% stake in Serum Institute-SCHOTT Pharma JV

On November 28, Moneycontrol was the first to report that billionaire Adar Poonawalla-led Serum Institute had agreed to sell 30-40 percent stake held by the top vaccine maker in SCHOTT Pharma to the US private equity firm.

Adar Poonawalla to sell Magma Insurance stake to Patanjali Ayurved, DS Group for Rs 4,500 crore

Post the sale, Patanjali and others will hold a 98 percent stake in Magma Insurance. Adar Poonawalla owns a 90 percent stake in Sanoti Properties, one of the entities selling its share in the general insurance company.

'Human being can’t be productive beyond 8, 9 hours per day': Adar Poonawalla weighs in on work-life balance

'A human being can’t be productive beyond 8 or 9 hours [per day],' Adar Poonawalla stated in an interaction with India Today. 'Sometimes you have to put in those hours [70 or 90 hours a week]. It’s fine. I do it. My staff do it, but you can’t do that every day.'

'My wife loves staring at me on Sundays': Adar Poonawalla on L&T chairman's remark

Serum Institute of India CEO Adar Poonawalla joined ranks with other business leaders such as Anand Mahindra in disagreeing with L&T chairman SN Subrahmanyan after he told his employees in a viral video: 'What do you do sitting at home? How long can you stare at your wife?'

Adar Poonawalla-led Serum Institute in talks with TPG to sell 40% stake in SCHOTT Poonawalla

In August 2021, Serum purchased 50% stake in the JV SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry

Who is Natasha Poonawalla? Friend of Bollywood actors, whose husband bought fifty percent stake in Karan Johar's Dharma

Natasha Poonawalla has long been a significant figure in India’s business, social, and philanthropic circles. As the chairperson of the Villoo Poonawalla Foundation and executive director of the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, Natasha is a powerful presence in her own right.

Memes galore as Adar Poonawalla buys 50% stake in Karan Johar’s Dharma: 'Kabhi Covid Na Kehna'

Billionaire vaccine maker Adar Poonawalla bought the stake for Rs 1,000 crore. Social media users called the development 'a booster shot for Bollywood'.

Adar Poonawalla to pick up 50% stake in Karan Johar's Dharma Productions for Rs 1,000 crore

Johar will retain the remaining 50 percent stake in Dharma and will continue to remain as the company's Executive Chairman. Apoorva Mehta will remain as the Chief Executive Officer.

Serum Institute joins CEPI network to supply affordable vaccines in Global South

The coalition said it is "investing up to $30 million" to build upon SII’s proven track record of "rapid response to outbreaks of infectious disease, expanding its existing ability to swiftly supply investigational vaccines in the face of such threats"

Adar Poonawalla to buy London’s most expensive house of 2023. It will cost him…

Adar Poonawalla, CEO of Serum Institute of India, will buy London's priciest house of 2023 for £138 million (Rs 1446 crore approximately).

Cyrus Poonawalla Group appoints Keki Mistry as strategic advisor 

Cyrus Poonawalla founded the Serum Institute of India in 1966. Now led by Adar Poonawalla, it is India's top biotech firm and the world's largest vaccine manufacturer

Poonawalla Fincorp reports highest quarterly disbursements of Rs 7,050 crore

As per a business update on NBFC, total disbursememnts grew about 143 percent year-on-year to Rs 7,050 crore in the June quarter compared to Rs 2,901 crore in the same period in the previous year.

Poonawalla Fincorp's rating upgraded to CRISIL AAA

The group has made domestic consumption a central component of its growth philosophy, and PFL will be crucial to carrying out this plan after Poonawalla Housing Finance (PHFL) has been divested.

Current COVID strain mild, SII has produced five to six million Covovax doses, says SII CEO Adar Poonawalla

India has recorded 12,193 fresh COVID-19 cases in a span of 24 hours, with the number of active cases of the infection going up to 67,556, the Union health ministry said on Saturday.

Adar Poonawalla advises elderly to mask up, take Covovax booster as COVID cases rise

Proposing the uptake of newly approved COVID vaccine, the CEO of Serum Institute said Omicron XBB & its variants can be severe for the elderly.

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM.

Adar Poonawalla: Serum plans to launch vaccines against cervical cancer, malaria this year

Serum Institute of India CEO said while the cervical cancer vaccine will be launched in India, the anti-malaria vaccine will be launched in Africa. Poonawalla said SII offered vaccines to China as boosters against COVID-19, but there was very little response from the authorities.

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

"Covovax will be approved as a booster in the next 10-15 days. It is actually the best booster because it works very well against Omicron, more than Covishield," said Poonawalla.

COVID-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

He said everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge and diverse population and also helped 70 to 80 nations during the COVID-19 pandemic.

Serum Institute to start free COVID vaccine supply to government, other manufacturers await order

The government has sent a consignment list for supplying 80 lakh doses of Covishield to different consignees to Serum Institute of India, which will start the supply soon, an official said.

Reports of rising COVID-19 cases in China a concern but India need not panic given excellent vaccination coverage: SII CEO Adar Poonawalla

Adar Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of positive samples to keep track of newer variants, if any, amid a spurt in cases in the US and China.

News of rising Covid cases in China is concerning, says Adar Poonawalla

Serum Institute of India chief Adar Poonawalla says that news of surging Covid cases in China is concerning, but India, with its excellent vaccination coverage, does not need to panic.